NLRP3 and COVID-19: Our recent inspections of the lungs of patients with COVID-19 revealed a significantly high expression of NLRP3 inflammasome along the around the vessel walls (endothelial layer) as compared to in lungs from non-COVID-19 affected individuals [15].